Epilepsy Research
Volume 27, Issue 3 , Pages 195-204, June 1997

A double-blind controlled clinical trial of oxcarbazepine versus phenytoin in adults with previously untreated epilepsy1

  • Pierre Alfred Bill

      Affiliations

    • Department of Neurology, Wentworth Hospital, Durban, South Africa
    • ,
  • Ulf Vigonius

      Affiliations

    • Novartis Sverige AB, Västra Frölunda, P.O. Box 1150, S-18311 Taeby, Sweden
    • Corresponding Author InformationCorresponding author.
    • ,
  • Harald Pohlmann

      Affiliations

    • Novartis Pharma AG, Basel, Switzerland
    • ,
  • Carlos Alberto M Guerreiro

      Affiliations

    • Department of Neurology, University of Campinas, UNICAMP, Campinas, Brazil
    • ,
  • Silvia Kochen

      Affiliations

    • Centre of Epilepsy, Division of Neurology, UBA, Hospital Ramos Mejia, Buenos Aires, Argentina
    • ,
  • David Saffer

      Affiliations

    • Department of Neurology, Baragwanath Hospital, Johannesburg, South Africa
    • ,
  • Alan Moore

      Affiliations

    • Novartis Pharma AG, Basel, Switzerland

Received 26 March 1997; received in revised form 11 April 1997; accepted 13 April 1997.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

PII: S0920-1211(97)00024-7

Epilepsy Research
Volume 27, Issue 3 , Pages 195-204, June 1997

Article Tools

* Image Usage & Resolution